Efficacy of teprotumumab therapy in patients with long-duration thyroid eye disease
PS Subramanian, RI Cho, A Kahana - Current opinion in …, 2023 - journals.lww.com
Efficacy of teprotumumab therapy in patients with long-durat... : Current Opinion in
Ophthalmology Efficacy of teprotumumab therapy in patients with long-duration thyroid eye …
Ophthalmology Efficacy of teprotumumab therapy in patients with long-duration thyroid eye …
Update on thyroid eye disease: Regional variations in prevalence, diagnosis, and management
YY Caroline, RL Ford, ST Wester… - Indian journal of …, 2022 - journals.lww.com
Thyroid eye disease (TED) is a rare disease that can lead to decreased quality of life,
permanent disfigurement, and vision loss. Clinically, TED presents with exophthalmos …
permanent disfigurement, and vision loss. Clinically, TED presents with exophthalmos …
Teprotumumab: A Major Advance in the Treatment of Thyroid Eye Disease Management
YY Caroline, JA Keen… - Advances in …, 2022 - advancesinophthalmology.com
Early studies on the natural history of TED suggest that it follows a biphasic pattern,
classically titled ''Rundle's curve.''The initial active state is thought to last 1 to 3 years before …
classically titled ''Rundle's curve.''The initial active state is thought to last 1 to 3 years before …
ADVANCES IN OPHTHALMOLOGY AND OPTOMETRY
YY Caroline, JA Keen, EM Shriver - Advances in Ophthalmology …, 2022 - books.google.com
ADVANCES IN OPHTHALMOLOGY AND OPTOMETRY Page 438 Advances in Ophthalmology
and Optometry 7 (2022) 383–400 ADVANCES IN OPHTHALMOLOGY AND OPTOMETRY …
and Optometry 7 (2022) 383–400 ADVANCES IN OPHTHALMOLOGY AND OPTOMETRY …